Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
WHO Adds Popular Weight-Loss Drugs to Essential Medicines List The World Health Organization (WHO) has officially added GLP-1 receptor agonist drugs, including Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro), to its Essential Medicines List
Strategic recommendations: Develop nutrient-dense, portion-controlled products and messaging that highlights fullness and wellness rather than restriction
Patients benefit from a fully integrated care journey: pre-visit screening, structured consultations, regular follow-up visits with integrated monitoring, standardized documentation, and evidence-based treatment algorithms with built-in safety protocols
Disclaimer: This article is for informational purposes only and does not constitute legal or medical advice
US$ 20.35
US$ 27.17
US$ 28.09
